Efi Melista

Xenoimmunobiology Assay Development Leader @United Therapeutics Corporation

Cambridge, MA, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2026 — Present

Xenoimmunobiology Assay Development Leader @United Therapeutics Corporation

View department →

EDUCATION

1999 — 2002

Cardiff University / Prifysgol Caerdydd

B.Sc., Genetics

SKILLS

Rt-PcrMicroarraysMolecular BiologyWestern BlottingSequencingBiotechnologyMicroscopyCell CultureBioinformaticsDna SequencingPolymerase Chain Reaction (Pcr)GenomicsHlaGenotypingNgsScienceBiochemistryQpcrMolecular GeneticsPcrNext Generation SequencingRna IsolationGeneticsLife SciencesCell BiologyResearch

ABOUT EFI MELISTA

Strategic biotech leader with 20+ years in genetics and molecular diagnostics, including nearly a decade in global product management and cross-functional leadership. Proven success driving the strategy, development, and commercialization of IVD/FDA-regulated NGS platforms and data software. Skilled in aligning complex portfolios with market and business priorities, mentoring high-performing teams, and building cross-cultural partnerships. Trusted advisor and communicator, translating scientific insight into business impact.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Efi Melista — Xenoimmunobiology Assay Development Leader at United Therapeutics Corporation in Cambridge, MA, US | Unifers